Novel Bicyclic Piperazine Derivatives of Triazolotriazine and Triazolopyrimidines as Highly Potent and Selective Adenosine A<INF>2</INF><INF>A</INF> Receptor Antagonists

MLA

Peng, H., et al. “Novel Bicyclic Piperazine Derivatives of Triazolotriazine and Triazolopyrimidines as Highly Potent and Selective Adenosine A2A Receptor Antagonists.” Journal of Medicinal Chemistry, vol. 47, no. 25, Dec. 2004, pp. 6218–29. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs6657307&authtype=sso&custid=ns315887.

APA

Peng, H., Kumaravel, G., Yao, G., Sha, L., Wang, J., Vlijmen, H. V., Bohnert, T., Huang, C., Vu, C. B., Ensinger, C. L., Chang, H., Engber, T. M., Whalley, E. T., & Petter, R. C. (2004). Novel Bicyclic Piperazine Derivatives of Triazolotriazine and Triazolopyrimidines as Highly Potent and Selective Adenosine A2A Receptor Antagonists. Journal of Medicinal Chemistry, 47(25), 6218–6229.

Chicago

Peng, H., G. Kumaravel, G. Yao, L. Sha, J. Wang, H. Van Vlijmen, T. Bohnert, et al. 2004. “Novel Bicyclic Piperazine Derivatives of Triazolotriazine and Triazolopyrimidines as Highly Potent and Selective Adenosine A2A Receptor Antagonists.” Journal of Medicinal Chemistry 47 (25): 6218–29. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs6657307&authtype=sso&custid=ns315887.